Capital Asset Advisory Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$452K Buy
+5,853
New +$452K 0.02% 179
2024
Q4
Sell
-3,623
Closed -$248K 317
2024
Q3
$248K Sell
3,623
-104
-3% -$7.13K 0.01% 278
2024
Q2
$348K Sell
3,727
-20
-0.5% -$1.87K 0.02% 229
2024
Q1
$347K Buy
3,747
+11
+0.3% +$1.02K 0.02% 227
2023
Q4
$285K Buy
3,736
+64
+2% +$4.88K 0.02% 243
2023
Q3
$261K Sell
3,672
-25
-0.7% -$1.78K 0.02% 262
2023
Q2
$345K Sell
3,697
-24
-0.6% -$2.24K 0.02% 237
2023
Q1
$308K Sell
3,721
-339
-8% -$28K 0.02% 255
2022
Q4
$304K Buy
+4,060
New +$304K 0.02% 268
2022
Q3
Sell
-5,081
Closed -$483K 498
2022
Q2
$483K Buy
+5,081
New +$483K 0.05% 233
2020
Q3
Sell
-10,470
Closed -$803K 569
2020
Q2
$803K Buy
+10,470
New +$803K 0.17% 111
2020
Q1
Sell
-10,755
Closed -$829K 537
2019
Q4
$829K Buy
10,755
+225
+2% +$17.3K 0.19% 100
2019
Q3
$772K Sell
10,530
-90
-0.8% -$6.6K 0.51% 36
2019
Q2
$654K Hold
10,620
0.5% 35
2019
Q1
$677K Hold
10,620
0.88% 18
2018
Q4
$542K Sell
10,620
-45
-0.4% -$2.3K 0.52% 44
2018
Q3
$619K Sell
10,665
-150
-1% -$8.71K 0.52% 45
2018
Q2
$525K Sell
10,815
-1,275
-11% -$61.9K 0.47% 46
2018
Q1
$562K Sell
12,090
-105
-0.9% -$4.88K 0.52% 48
2017
Q4
$458K Sell
12,195
-1,935
-14% -$72.7K 0.42% 63
2017
Q3
$515K Sell
14,130
-585
-4% -$21.3K 0.47% 54
2017
Q2
$575K Buy
+14,715
New +$575K 0.37% 65
2016
Q2
Sell
-15,000
Closed -$441K 70
2016
Q1
$441K Buy
+15,000
New +$441K 0.48% 45